Names and pronunciation
(en-zal-u′ta-mide) Xtandi
PDF page 475
Drug reference
(en-zal-u′ta-mide) Xtandi
PDF page 475
Func. class.: Antineoplastic hormone
PDF page 475
Chem. class.: Nonsteroidal antiandrogen
PDF page 475
USES: Metastatic, castration-resistant prostate cancer in those who have received DOCEtaxel
PDF page 475
CONTRAINDICATIONS: Preg- nancy, women, hypersensitivity
PDF page 475
DOSAGE AND ROUTES • Adult: PO 160 mg (4 × 40-mg caps) daily. If a patient experiences a grade 3 or higher toxicity or an intolerable adverse effect, withhold dosing for 1 wk or until symptoms improve to grade 2 or less, then resume at the same or a reduced dosage (120 or 80 mg), if warranted • The concomitant use of strong CYP2C8 give 80 mg once daily; CYP3A4 inducers 240 mg daily
PDF page 475
Available forms: Capsules 40 mg
PDF page 475
• Adult: PO 160 mg (4 × 40-mg caps) daily. If a patient experiences a grade 3 or higher toxicity or an intolerable adverse effect, withhold dosing for 1 wk or until symptoms improve to grade 2 or less, then resume at the same or a reduced dosage (120 or 80 mg), if warranted
PDF page 475